Member News
-
Scandium Canada Announces Closing of Private Placements
September 20, 2024 (Source) — Scandium Canada Ltd. (TSX-V: SCD) (OTC: SCDCF) (the “Corporation”) announces closing of a non-brokered private placement…
-
DIAGNOS Announces Closing of Private Placement
September 20, 2024 (Source) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
-
Nano One Closes on $5 Million Sale of Vacant Land
September 20, 2024 (Source) — Highlights: On September 12, 2024 Nano One closed on the previously announced sale…
-
Notice of Annual General Meeting and Proxy Form
Meteoric 9-20-24Download
-
Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
September 19, 2024 (Source) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the “Company” or “Coeptis”), a biopharmaceutical company developing…
-
Scandium Canada Announces a Private Placement of $1,000,000
September 18, 2024 (Source) — Scandium Canada Ltd. (TSX-V: SCD) (OTC: SCDCF) (the “Corporation”) announces that its intention to complete a…
-
First Phosphate Reports Initial Mineral Resource Estimate on its Bégin-Lamarche Phosphate Deposit in the Saguenay-Lac-Saint-Jean Region of Québec, Canada
September 18, 2024 (Source) — First Phosphate Corp (CSE: PHOS) (OTC: FRSPF) (FSE: KD0) (“First Phosphate” or the…
-
Voyageur Pharmaceuticals Appoints Dr. Iryna Saranchova as Chief Science Officer, Enhancing the Company’s Research and Innovation Leadership
September 17, 2024 (Source) — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (USA: VYYRF) (“Voyageur” or the “Company”) proudly announces…
